Dekompression peripherer Nerven als Behandlungskonzept der diabetischen Polyneuropathie

Zusammenfassung

Die Polyneuropathie als Spätfolge der diabetischen Erkrankung mit ihren Konsequenzen Ulzeration und Amputation wird in ihrer pathophysiologischen Ursache, ihrer sozioökonomischen und sozialmedizinischen Relevanz kurz skizziert und die Ergebnisse der Dekompression peripherer Nerven an der unteren Extremität anhand einer systematischen Literaturrecherche in Pubmed, Embase und Cochrane gelisteten Journalen hinsichtlich Sensibilität, Schmerz, Ulzeration und Amputation analysiert und ausgewertet. Die Dekompression peripherer Nerven erweist sich als sehr gutes Behandlungskonzept zur Wiederherstellung bzw. Verbesserung der Sensibilität, Verminderung der Schmerzsymptomatik und Reduktion von Ulzerationen und Amputationen.

Abstract

Polyneuropathy causing ulceration and amputation as a long-term consequence of diabetes mellitus is analysed for its pathophysiology, socioeconomic and medical relevance. Outcomes of decompression of peripheral nerves on the lower extremity regarding sensation, pain, development, and recurrence of ulceration, and amputation is evaluated by a systematic literature review in pubmed, medline and embase. Decompression of peripheral nerves in diabetic peripheral neuropathy seems to be a good treatment option for restoring sensation, decreasing pain, as well as for avoiding the development and recurrence of ulceration and amputation.

Schlüsselwörter

periphere Nerven - Diabetes mellitus - Polyneuropathie - untere Extremität - Dekompression

Key words

peripheral nerves - diabetes mellitus - polyneuropathy - lower extremity - decompression

• Literatur

• 1 International Diabetes Federation (IDF) Diabetes Atlas Second Edition 2003
• 2 Richter-Kuhlmann E. Deutscher Gesundheitssurvey des Robert-Koch-Instituts: Zivilisationskrankheiten nehmen zu. Deutsches Ärzteblatt 2012; 109 A-1376/B-1191/C-1171
• 3 Imperatore G, Boyle J, Thompson T et. al. Projections of Type I and Type 2 Diabetes Burden in the US Populatino Aged<20 Years through 2050. Diabetes Care 2012; 35: 2515-2520
• 4 Apelquist J, Ragnarson-Tennvall G, Larsson J et. al. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle International 1995; 16: 388-395
• 5 Apelquist J, Ragnarson-Tennvall G, Persson U et al. Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation. Journal of Internal Medicine 1994; 235: 463-471
• 6 Liebel A, Neiß A, Spannheimer A et al. Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany – results from the CODE-2 study. Exp Clin Endocrinol Diabetes 2002; 110: 10-16
• 7 Diabetes Care and Research in Europe . The St. Vincet decleration. Diabetes Medicine 1990; 7: 360
• 8 European framework for Diabetes Prevention and Care, Dublin 2004 http://www.idf.org/webdata/docs/StakeholderPresentation.pdf
• 9 | Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. Diabetes in America. 2^nd Edition 1995: 409-428
• 10 Grunfield C. Diabetic foot ulcers: etiology, treatment, and prevention. Advances in Internal Medicine 1992; 37: 103-132
• 11 Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983; 6: 87-91
• 12 Aszmann OC, Tassler PL, Dellon AL. Changing the Natural History of Diabetic Neuropathy: Incidence of ulcer/amputation in the contralateral limb of patients with a unilateral nerve decompression procedure. Ann Plast Surg 2004; 53: 517-522
• 13 The Diabetes Control and Complications Trial (DCCT) Research Group . Factors in the development of diabetic neuropathy: baseline analysis of neuropathy in the feasibility phase of the Diabetes Control and Complications Trial (DCCT). Diabetes 1988; 37: 476
• 14 Rathur HM, Boulton AJ. The neuropathic diabetic foot. Natural Clinical Practice. Endocrinology and Metabolism 2007; 3: 14-25
• 15 Sima AA, Bril V, Nathaniel V et al. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. New England Journal of Medicine 1988; 319: 548-555
• 16 Greene DA, Arezzo JC, Brown MB. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Neurology 1999; 53: 580-591
• 17 Apfel SC, Kessler JA, Arornato BT et al. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy, NGF Study Group. Neurology 1998; 51: 695-702
• 18 Dellon AL, Mackinnon SE, Seiler IV WA. Susceptibility of the diabetic nerve to chronic compression. Annals of Plastic Surgery 1988; 20: 117-119
• 19 Dahlin LB, Meiri KF, Mc Lean WG et al. Effect of nerve compression on fast axonal transport in streptozotocin-induced diabetes mellitus. An experimental study in the sciatic nerve of rats. Diabetologia 1986; 29: 181-185
• 20 Mackinnon SE, Dellon AL, Hudson AR et al. Chronic nerve compression – An experimental model in the rat. Annals of Plastic Surgery 1984; 13: 112-120
• 21 Mackinnon SE, Dellon AL, Hudson AR. A primate model of chronic nerve compression. Journal of Reconstructive and Microsurgery 1985; 1: 185-194
• 22 Dellon AL. Treatment of symptomatic diabetic neuropathy by surgical decompression of multiple peripheral nerves. Plastic Reconstructive Surgery 1992; 89: 689-697
• 23 Wiemann TJ, Patel VG. Treatment of hyperesthetic neuropythic pain in diabetics: decompression of the tarsal tunnel. Annals of Surgery 1995; 221: 660-665
• 24 Caffee HH. Treatment of diabetic neuropathy by decompression of the posterior tibial nerve. Plastic and Reconstructive Surgery 2000; 106: 813-815
• 25 Aszmann OA, Kress KM, Dellon AL. Results of decompression of peripheral nerves in diabetics. A prospective blinded study. Plastic and Reconstructive Surgery 2000; 106: 816-822
• 26 Wood WA, Wood MA. Decompression of peripheral nerves for diabetic neuropathy in the lower extremity. Journal of Foot Ankle Surgery 2003; 42: 268-275
• 27 Valdivia JM, Maloney CM, Dellon AL et al. Surgical treatment of peripheral neuropoathy: outcomes from 100 consecutive decompressions. Journal of American Podiatric and Medical Association 2005; 95: 451-454
• 28 Siemionow M, Alghoul M Molski, et al. Clinical Outcome of Peripheral Nerve Decompression in Diabetic and Nondiabetic Peripheral Neuropathy. Annals of Plastic Surgery 2006; 47: 385-390
• 29 Lee CH, Dellon AL. Prognostic Ability of Tinel Sign in Determinning outcome for Decompression Surgery in Diabetic and Non-Diabetic Neuropathy. Annals of Plastic Surgery 2004; 53: 523-527
• 30 Kobloch K, Gohritz A, Vogt PM. Operative Nervendekompression an der unteren Extremität bei diabetischer Polyneuropathie. Oper Orthop Traumatol 2012; 24: 74-79
• 31 Dellon AL, Muse VL, Nickerson DS. A Positive Tinel Sign as Predictor of Pain Relief or Sensory Recovery after Decompression of Chronic Tibial Nerve Compression in Patients with Diabetic. Neuropathy J Reconstr Microsurg 2012; 28: 235-240
• 32 Dellon AL, Muse VL, Nickerson DS. Prevention of Ulceration, Amputation, and Reduction of Hospitalization: Outcomes of a Prospective Multicenter Trial of Tibial Neurolysis in Patients with Diabetic . Neuropathy J Reconstr Microsurg 2012; 28: 241-246
• 33 Zhang W, Shiting L, Zheng X. Evaluation of the clinical efficacy of multiple lower extremity nerve decompression in diabetic peripheral neuropathy. J Neurol Surg A Cent Eur Neurosurg 2013; 74: 96-100
• 34 Chaudhry V, Russel J, Belzberg A. Decompression surgery of lower limbs for symmetrical diabetic peripheral neuropathy. Cochrane Database System Review 2008; 16 CD006152
• 35 AAEM Quality Assurance Commitee . Literature review of the usefulness of nerve conduction studies and electromyography for the evaluation of patients with carpal tunnel syndrome. Muscle Nerve 1993; 16: 1392-1414
• 36 Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 2002; 25: 565-569